A combination of ligand SAR and receptor site-directed mutagenesis reveals requirements for antagonist activity at the melanocortin-3 receptor.

Source:http://linkedlifedata.com/resource/pubmed/id/19400209

Download in:

View as

General Info

PMID
19400209